BPTH Stock Bio-Path Holdings Inc - Complete Overview

Nasdaq / Pharmaceutical Products / Healthcare / BPTH Stock

Bio-Path Holdings Inc (BPTH) price per share as of 24 May 2018
USD
Your sentiment
COLDTRENDOMETERHOT
Shares Outstanding 11.34M
Avg Daily Volume 305.35K
Market Cap 19.96M
Volatility 88.86% HIGH

BIO-PATH HOLDINGS INC (BPTH) OVERVIEW

BPTH stock is a pharmaceutical products company traded on Nasdaq. It is valued at 19.96M US dollars. There are 11.34M shares outstanding which Bio-Path Holdings Inc issued to investors. Volatility of the stock is HIGH, and the daily volume is 88.86% stock on average. It brought investors a total return of 341.03% over the last 12 months. Bio-Path Holdings Inc stock is relatively cheap. It's P/E ratio is below the market average.

Bio-Path Holdings Inc (BPTH) STOCK PRICE PERFORMANCE

BPTH SHAREHOLDER'S RETURN

Earnings Per Share 0.00
Dividends Per Share 0.00
12 Months Price Performance High
Total Return High

BPTH LATEST NEWS

Bio-Path Holdings' (BPTH) CEO Peter Nielsen on Q1 2018 Results - Earnings Call Transcript

Bio-Path Holdings, Inc. (NASDAQ:BPTH) Q1 2018 Earnings Conference Call April 16, 2018 8:30 PM ET Executives Will O’Connor – Investor Relations Peter Nielsen – President and Chief Executive Officer Ant

Bio-Path Holdings' (BPTH) CEO Peter Nielsen on Q4 2017 Results - Earnings Call Transcript

Bio-Path Holdings, Inc. (NASDAQ:BPTH) Q4 2017 Earnings Conference Call April 03, 2018 08:00 AM ET Executives Will O’Connor - Stern Investor Relations Peter Nielsen - President and Chief Executive Offi

Bio-Path Holdings' (BPTH) CEO Peter Nielsen on Q2 2017 Results - Earnings Call Transcript

Bio-Path Holdings, Inc. (NASDAQ:BPTH) Q2 2017 Earnings Conference Call August 10, 2017 08:30 PM ET Executives Will O'Connor - Stern Investor Relations Peter Nielsen - President, Chief Executive Office

Bio-Path Holdings' (BPTH) CEO Peter Nielsen on Q1 2017 Results - Earnings Call Transcript

Bio-Path Holdings, Inc. (NASDAQ:BPTH) Q1 2017 Earnings Conference Call May 11, 2017 8:30 AM ET Executives Will O'Connor - Stern Investor Relations Peter Nielsen - President, Chief Executive Officer An

Bio-Path Holdings (BPTH) Looks Good: Stock Moves 13% Higher

Bio-Path Holdings, Inc. (BPTH) shares rose over 13% in the last trading session.

Bio-Path Holdings' (BPTH) CEO Peter Nielsen on Q4 2016 Results - Earnings Call Transcript

Bio-Path Holdings Inc (NASDAQ:BPTH) Q4 2016 Earnings Conference Call March 15, 2017 08:30 AM ET Executives Will O’Connor - Stern Investor Relations Peter Nielsen - President and CEO Ulrich Mueller - C

Bio-Path Holdings Inc (BPTH) TECHNICAL INDICATORS

Name Value Action
RSI(14) 45.76 Neutral
CMO(14) -8.48 Sell
ADX(14) 33.24 N/A
Williams %R -86.67 Overbought

BPTH FORUM DISCUSSIONS